HHLA2 Expression Demonstrated by Immunohistochemistry in Non-Ductal Pancreatic Tumors

被引:0
|
作者
de Gonzalez, Anne K. Koehne [1 ]
Yan, Han [1 ]
Su, Gloria H. [1 ]
Remotti, Helen
机构
[1] Columbia Univ, New York, NY USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1896
引用
收藏
页码:681 / 681
页数:1
相关论文
共 50 条
  • [21] In search of a stem cell in pancreatic ducts: The nature of round, non-ductal appearing cells in human pancreatic ducts
    Vyas, P
    Andea, A
    Sarkar, F
    Leach, S
    Cheng, J
    Adsay, NV
    LABORATORY INVESTIGATION, 2003, 83 (01) : 287A - 288A
  • [22] In search of a stern cell in pancreatic ducts: The nature of round, non-ductal appearing cells in human pancreatic ducts
    Vyas, P
    Andea, A
    Sarkar, F
    Leach, S
    Cheng, J
    Adsay, NV
    MODERN PATHOLOGY, 2003, 16 (01) : 287A - 288A
  • [23] Expression of HHLA2, TMIGD2, and GITR in salivary gland adenoid cystic carcinoma and mucoepidermoid carcinoma
    Zhang, Meng-Jie
    Wang, Shuo
    Wu, Cong-Cong
    Wu, Lei
    Sun, Zhi-Jun
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2022, 51 (04) : 379 - 387
  • [24] HHLA2 and TMIGD2 gene expression in breast carcinoma: correlation with clinicopathological factors and prognostic value
    Montoyo Pujol, Y. G.
    Llopis-Gomez, A.
    Manresa-Corbalan, D. A.
    Garzon-Arana, A.
    Martin Bayona, T.
    Delgado Garcia, S.
    Ballester, H.
    Ponce Lorenzo, J.
    Castellon Molla, E.
    Peiro Cabrera, G.
    VIRCHOWS ARCHIV, 2024, 485 : S56 - S57
  • [25] Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
    Nishihara, Daisaku
    Kijima, Toshiki
    Arai, Kyoko
    Kamai, Takao
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (04) : 867 - 874
  • [26] Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
    Daisaku Nishihara
    Toshiki Kijima
    Kyoko Arai
    Takao Kamai
    International Urology and Nephrology, 2023, 55 : 867 - 874
  • [27] Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
    Janakiram, Murali
    Chinai, Jordan M.
    Fineberg, Susan
    Fiser, Andras
    Montagna, Cristina
    Medavarapu, Ramadevi
    Castano, Ekaterina
    Jeon, Hyungjun
    Ohaegbulam, Kim C.
    Zhao, Ruihua
    Zhao, Aimin
    Almo, Steven C.
    Sparano, Joseph A.
    Zang, Xingxing
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2359 - 2366
  • [28] Expression of novel immune checkpoints HHLA2 and B7x on circulating tumor cells (CTCs) of pediatric, adolescent and young adult solid tumors
    Yuan, Ziqiang
    Libutti, Steven K.
    Cole, Peter
    Moerdler, Scott
    CANCER RESEARCH, 2024, 84 (17)
  • [29] HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
    Jing, Chu-Yu
    Fu, Yi-Peng
    Yi, Yong
    Zhang, Mei-Xia
    Zheng, Su-Su
    Huang, Jin-Long
    Gan, Wei
    Xu, Xin
    Lin, Jia-Jia
    Zhang, Juan
    Qiu, Shuang-Jian
    Zhang, Bo-Heng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [30] Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas
    Katalin Borka
    Péter Kaliszky
    Erzsébet Szabó
    Gábor Lotz
    Péter Kupcsulik
    Zsuzsa Schaff
    András Kiss
    Virchows Archiv, 2007, 450